Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 3 | 2019 | 199 | 0.790 |
Why?
|
| Rhizopus | 1 | 2019 | 1 | 0.620 |
Why?
|
| Xylose | 1 | 2019 | 12 | 0.620 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2019 | 64 | 0.610 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 100 | 0.590 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2019 | 110 | 0.580 |
Why?
|
| Lactic Acid | 1 | 2019 | 112 | 0.580 |
Why?
|
| Prostatic Neoplasms | 8 | 2014 | 1092 | 0.430 |
Why?
|
| Poliovirus Vaccines | 1 | 2012 | 2 | 0.390 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 38 | 0.370 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 62 | 0.360 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 80 | 0.360 |
Why?
|
| Hela Cells | 1 | 2012 | 376 | 0.350 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2010 | 39 | 0.330 |
Why?
|
| Fermentation | 3 | 2019 | 39 | 0.310 |
Why?
|
| Universities | 2 | 2012 | 559 | 0.310 |
Why?
|
| Peptides | 1 | 2012 | 372 | 0.290 |
Why?
|
| Peptide Fragments | 1 | 2010 | 307 | 0.280 |
Why?
|
| Ethanol | 3 | 2019 | 224 | 0.270 |
Why?
|
| Biomedical Research | 1 | 2012 | 502 | 0.260 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1019 | 0.190 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2002 | 8 | 0.180 |
Why?
|
| Synaptic Vesicles | 1 | 2002 | 31 | 0.180 |
Why?
|
| Fungal Proteins | 2 | 2019 | 142 | 0.180 |
Why?
|
| Crotonates | 1 | 2021 | 1 | 0.170 |
Why?
|
| Toluidines | 1 | 2021 | 3 | 0.170 |
Why?
|
| Hydroxybutyrates | 1 | 2021 | 3 | 0.170 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 2021 | 13 | 0.170 |
Why?
|
| Nitriles | 1 | 2021 | 81 | 0.170 |
Why?
|
| Quercetin | 2 | 2012 | 46 | 0.160 |
Why?
|
| Cell Movement | 3 | 2012 | 655 | 0.160 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2019 | 12 | 0.160 |
Why?
|
| Adenocarcinoma | 3 | 2010 | 291 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 247 | 0.150 |
Why?
|
| Symporters | 1 | 2019 | 15 | 0.150 |
Why?
|
| Prostate | 2 | 2010 | 155 | 0.150 |
Why?
|
| Transgenes | 1 | 2019 | 65 | 0.150 |
Why?
|
| Sequence Deletion | 1 | 2019 | 93 | 0.150 |
Why?
|
| DNA Damage | 2 | 2012 | 356 | 0.150 |
Why?
|
| Glucosides | 1 | 2018 | 21 | 0.140 |
Why?
|
| Cellulose | 1 | 2018 | 24 | 0.140 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1455 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 244 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2016 | 462 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.130 |
Why?
|
| Lactose | 1 | 2016 | 16 | 0.130 |
Why?
|
| Gene Expression | 1 | 2019 | 701 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2014 | 518 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1124 | 0.120 |
Why?
|
| Alabama | 2 | 2012 | 52 | 0.120 |
Why?
|
| Cell Line, Tumor | 6 | 2014 | 2676 | 0.120 |
Why?
|
| Protein Binding | 2 | 2012 | 1082 | 0.110 |
Why?
|
| Interinstitutional Relations | 2 | 2013 | 51 | 0.110 |
Why?
|
| Humans | 15 | 2021 | 43102 | 0.100 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.100 |
Why?
|
| Minority Health | 1 | 2013 | 95 | 0.100 |
Why?
|
| Poliomyelitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Receptors, CXCR3 | 1 | 2012 | 31 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2012 | 121 | 0.090 |
Why?
|
| Neoplasms | 3 | 2013 | 1377 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 74 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2012 | 346 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2012 | 127 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 127 | 0.090 |
Why?
|
| Ruta | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 383 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2010 | 109 | 0.080 |
Why?
|
| Ethics, Research | 1 | 2010 | 18 | 0.080 |
Why?
|
| Nocodazole | 1 | 2010 | 8 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2010 | 20 | 0.080 |
Why?
|
| Health Status Disparities | 2 | 2013 | 719 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 220 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1180 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1542 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2010 | 64 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 329 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2012 | 512 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 876 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 299 | 0.070 |
Why?
|
| Communication | 1 | 2010 | 210 | 0.070 |
Why?
|
| Male | 9 | 2021 | 23409 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 269 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 590 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 706 | 0.070 |
Why?
|
| Antioxidants | 1 | 2012 | 443 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 277 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 134 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2012 | 735 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 968 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2011 | 302 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2010 | 434 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1271 | 0.060 |
Why?
|
| Apoptosis | 2 | 2012 | 1568 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2012 | 2157 | 0.060 |
Why?
|
| Cell Line | 2 | 2010 | 1410 | 0.050 |
Why?
|
| Cell Survival | 2 | 2021 | 945 | 0.050 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2002 | 2 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 20 | 0.050 |
Why?
|
| Synaptosomes | 1 | 2002 | 23 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 92 | 0.050 |
Why?
|
| Exocytosis | 1 | 2002 | 49 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2002 | 48 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2002 | 141 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2012 | 32 | 0.040 |
Why?
|
| Gene Products, tax | 1 | 2021 | 4 | 0.040 |
Why?
|
| HTLV-I Infections | 1 | 2021 | 33 | 0.040 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2021 | 35 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 149 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 124 | 0.040 |
Why?
|
| Cyclin B1 | 2 | 2012 | 18 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 290 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2002 | 131 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 91 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2012 | 411 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 321 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 665 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 12222 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 386 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 8214 | 0.040 |
Why?
|
| Calcium | 1 | 2002 | 491 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 883 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2002 | 986 | 0.040 |
Why?
|
| Neurospora crassa | 1 | 2018 | 10 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 220 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 113 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 561 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 518 | 0.030 |
Why?
|
| Cellobiose | 1 | 2016 | 1 | 0.030 |
Why?
|
| beta-Glucosidase | 1 | 2016 | 6 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 37 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 37 | 0.030 |
Why?
|
| Mice | 2 | 2010 | 6644 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 64 | 0.030 |
Why?
|
| Brain | 1 | 2002 | 1472 | 0.030 |
Why?
|
| Community Networks | 1 | 2013 | 107 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 70 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 77 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 81 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 178 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 21 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 21 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2012 | 34 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 102 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 56 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 76 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 47 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 296 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 195 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 92 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 13872 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 158 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 57 | 0.020 |
Why?
|
| Morals | 1 | 2010 | 15 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 704 | 0.020 |
Why?
|
| Food-Drug Interactions | 1 | 2010 | 4 | 0.020 |
Why?
|
| Androgens | 1 | 2010 | 106 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 227 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 16992 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 52 | 0.020 |
Why?
|
| G2 Phase | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 152 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 667 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 508 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 96 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1413 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 121 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 238 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2010 | 208 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 307 | 0.020 |
Why?
|
| Female | 2 | 2021 | 24698 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 1857 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2853 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5080 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.010 |
Why?
|